Table 1. Patients; Characteristics at Baseline .
| Group (n=60) | NAC Group (n=25) | Control Group (n=28) | P Value* |
| Age, year, mean ± SD | 68.00 ± 13.78 | 57.74 ± 8.32 | 0.003 |
| Sex (F/M) | 17/8 | 16/12 | 0.42 |
| BMI (kg/m2) | 26.37 ± 2.38 | 27.88 ± 2.75 | 0.06 |
| Wagner classification grade of DFO (grade 3/grade 4) | 11/14 | 18/10 | 0.55 |
| Ulcer duration (months) | 1.75 ± 0.96 | 2.21 ± 0.63 | 0.12 |
| Number of DFU | |||
| 1 | 11 | 18 | 0.55 |
| > 1 | 14 | 10 | |
| Regimen of antibiotic therapy | |||
| Vancomycin + meropenem | 10 | 15 | |
| Vancomycin + ciprofloxacin + meropenem | 11 | 9 | |
| Others | 4 | 3 | |
| Microbiologic results of wound swab culture | |||
| Negative | 12 | 8 | |
| Positive | 13 | 20 |
DFO, Diabetic foot osteomyelitis; BMI, Body Mass Index; DFU, Diabetic foot ulcer; n, Number of patients.
* P value < 0.05 is significant.